News

Mass. residents who take GLP-1 drugs for obesity tend to be white and affluent. But who needs them most?
The trends worry health experts, who say the medicines have potential to narrow differences in obesity rates among ...
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
Clinical trial participants who took tirzepatide, the drug sold as Zepbound, lost an average of 50 pounds (22.8 kilograms) ...
FDA to boost surprise inspections at foreign-based food, medical plants
The U.S. Food and Drug Administration said Tuesday it will expand its use of unannounced inspections at foreign manufacturing ...
Wellness companies eager to avoid WeightWatchers' fate embrace weight-loss drugs
WeightWatchers filed for bankruptcy on Tuesday as Americans shunned its offerings in favor of Novo and Lilly drugs and copies ...
Critic of drug industry and COVID-19 measures to lead FDA vaccine program
The Food and Drug Administration says that a prominent medical contrarian and critic of the drug industry will head its ...